Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Oct 27, 2024; 16(10): 3185-3201
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3185
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3185
Figure 2 Receiver operating characteristics curve and survival analyses of serum recurrence score in the training cohort.
A: Receiver operating characteristics (ROC) curves of serum recurrence score (SRS) and top six (AUC) serum-derived variables for predicting early recurrence (ER). The AUC of SRS was superior to the AUCs of other serum-derived variables; B: Time-dependent ROC curve of SRS for predicting recurrence, the AUCs of SRS varied over time (months); C: Stacked plot showing significantly different ratios of ER and delayed recurrence, in the high-SRS (SRS > 0.53) and low-SRS (SRS ≤ 0.53) groups, respectively (P value = 2.719e-09); D and E: Kaplan-Meier survival analysis for patients with high SRS and low SRS. The high-SRS group showed significantly poorer recurrence free survival and overall survival compared with the low-SRS group. SRS: Serum recurrence score; ROC: Receiver operating characteristics; AUC: Area under the curve; ER: Early recurrence.
- Citation: He H, Zou CF, Jiang YJ, Yang F, Di Y, Li J, Jin C, Fu DL. Recurrence scoring system predicting early recurrence for patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy and portomesenteric vein resection. World J Gastrointest Surg 2024; 16(10): 3185-3201
- URL: https://www.wjgnet.com/1948-9366/full/v16/i10/3185.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i10.3185